维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Judson PA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Compparative effect of trypsin and chy- motrypsin on blood group antigens显示文摘	Judson PA Anstee DJ	1977	Med Lab Sci1977，34，1：	1
2	A prosepective ran- domized trial of thalidomide with topotecan compared with potitecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Donwns LS Judson PL Argenta PA	2008	Cancer2008，112，2：	1
3	Aprospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs LS Jr Judson PL Argenla PA		0，，02：	1
4	A phase I study ofifosfamide,paclitaxe,and carboplatin in advanced and recurrent cervical cancer显示文摘	Downs Ls Jr Judson PL Argenta PA	2003	Gynecol Oncol2003，95，2：	1
5	A phase I1 study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer显示文摘	Argenta PA Thomas SG Judson PL	2009	Gynecol Oncol2009，113，2：	1
6	A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs LS Jr Judson PL Argenta PA	2008	Cancer2008，112，2：	1
7	Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines显示文摘	Judson PL Watson JM Gehrig PA	1999	Cancer Res1999，59，5：	1
8	A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer 显示文摘	Argenta PA Thomas SG Judson PL	2009	Gynecol 0ncol2009，113，2：	1
9	A phase Ⅰ study of ifosfamide,paclitaxel;and carboplatin in advanced and recurrent cervical cancer显示文摘	Downs Ls Jr Judson PL Argenta PA	2003	Gynecol Oncol2003，95，2：	1
10	A phase I study of ifosfamide,paclitaxel and carboplatin in advanced and recurrent cervical cancer显示文摘	Downs LS Judson PL Argenta PA	2004	Gynecol Oncol2004，95，2：	1
11	A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs LS Jr Judson PL Argenta PA		0，，02：	1
12	Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy显示文摘	Judson PL Watson JM Gehrig PA	1999	Cancer Res1999，59，10：	1
13	A prosepective randomized trial of thalidomide with topotecan compared with topitecan alone in women with recrurrent epithelial ovarian carcinoma显示文摘	Donwns LS Judson PL Argenta PA	2008	Cancer2008，112，2：	1
14	A prospective random- ized trim of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma 显示文摘	Downs LS Jr Judson PL Argenta PA	2008	Cancer2008，112，2：	1
15	A prospective random- ized trial of thalidomide with topotecan compared with to- potecan alone in women with recurrent epithelial ovarian carcinoma 显示文摘	Downs LS Judson PL Argenta PA	2008	Cancer2008，112，2：	1
16	A phaseⅠstudy of ifosfamide,paclitaxel,and carboplatin in advanced and recurrent cervical cancer显示文摘	Downs Jr Judson PL Argenta PA	2004	Gynecol Oncol2004，95，2：	1
17	Aprospective randomized trial of thalidomide with topotccan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs LS Jr Judson PL Argenta PA	2008	Cancer2008，112，2：	1
18	A phase Ⅰ study of ifosfamide,paclitaxel,and carboplatin in advanced and recurrent cervical cancer显示文摘	Downs Ls Jr Judson PL Argenta PA	2003	Gynecol Oncol2003，95，2：	1
19	Expression of RHD and RHCE gene products using retroviral transduction of K562 cells establishes the molecular basis of Rh blood group antigens显示文摘	Smythe J S Avent ND Judson PA	1996	Blood1996，87，7：	1
20	A prosepective ran- domized trial of thalidomide with topotecan compared with to- piteean alone in women with recrurrent epithelial ovarian carcino- ma 显示文摘	Donwns LS Judson PL Argenta PA	2008	Cancer2008，112，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示